Concepedia

Jun Anabuki

JA

4

Publications

248

Citations

4

H-Index

1990

Active since

Affiliations

The University of Tokyo(Current)

Mitsubishi Tanabe Pharma Corporation

Jun Anabuki is an author at The University of Tokyo specializing in medicine, pharmacology, and electrophysiology.

Top concepts

MedicinePharmacologyPhysiologyBiochemistryDrug DiscoveryPharmacotherapyElectrophysiologyMolecular PhysiologyDiabetesMechanobiology

Publications per year

1990–2012

4

Publications

4

Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): A highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

Tomohiro Yoshida, Fumihiko Akahoshi, Hiroshi Sakashita et al. · Bioorganic & Medicinal Chemistry · 2012 · 148 citations · Full text

Biochemistry, Medicine, Rational Drug Design +7

A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations

Sayaka Fukuda-Tsuru, Jun Anabuki, Yuji Abe et al. · European Journal of Pharmacology · 2012 · 47 citations

Metabolic Syndrome, Diabetes Management, Biochemistry +9

Mechanisms of pinacidil-induced vasodilatation

Jun Anabuki, Masatoshi Hori, Hiroshi Ozaki et al. · European Journal of Pharmacology · 1990 · 32 citations

Mechanobiology, Molecular Physiology, Medicine +6

Muscarinic stimulation does not induce rhoA/ROCK-mediated Ca 2+ sensitization of the contractile element in chicken gizzard smooth muscle

Jun Anabuki, Masatoshi Hori, Kohichi Hayakawa et al. · Pflügers Archiv - European Journal of Physiology · 2000 · 21 citations

Rhoa/rock-mediated Ca 2+, Muscle Function, Molecular Physiology +9

Rows per page

1–4 of 4